CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.3200
0.00 (0.00%)
At close: Dec 5, 2025
CytoDyn Cash Flow Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
| Net Income | -21.02 | 3.75 | -49.84 | -79.82 | -210.82 | -176.47 | Upgrade
|
| Depreciation & Amortization | 0.02 | 0.02 | 0.03 | 0.18 | 0.78 | 1.8 | Upgrade
|
| Other Amortization | 0.28 | 0.41 | 1.65 | 2.2 | 3.05 | 3.66 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 10.05 | Upgrade
|
| Stock-Based Compensation | 1.66 | 1.61 | 2.42 | 4.28 | 6.24 | 10.43 | Upgrade
|
| Other Operating Activities | -0.41 | 1.63 | 23.11 | 49.26 | 127.81 | 58.08 | Upgrade
|
| Change in Inventory | - | - | - | - | 2.06 | -79.36 | Upgrade
|
| Change in Accounts Payable | 3.89 | -11.33 | 10.77 | -3.1 | -2.71 | 53.01 | Upgrade
|
| Change in Other Net Operating Assets | -1.07 | -4.84 | 0.89 | 1.9 | -4.13 | 1.23 | Upgrade
|
| Operating Cash Flow | -16.66 | -8.77 | -10.98 | -25.11 | -77.72 | -117.57 | Upgrade
|
| Capital Expenditures | - | - | - | - | - | -0.12 | Upgrade
|
| Investing Cash Flow | - | - | - | - | - | -0.12 | Upgrade
|
| Long-Term Debt Issued | - | - | 2.31 | 0.9 | - | 100 | Upgrade
|
| Total Debt Issued | - | - | 2.31 | 0.9 | - | 100 | Upgrade
|
| Long-Term Debt Repaid | - | -0.71 | - | - | - | -0.95 | Upgrade
|
| Total Debt Repaid | -0.14 | -0.71 | - | - | - | -0.95 | Upgrade
|
| Net Debt Issued (Repaid) | -0.14 | -0.71 | 2.31 | 0.9 | - | 99.05 | Upgrade
|
| Issuance of Common Stock | 1.21 | 1.19 | 9.44 | 26.23 | 42.62 | 22.27 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -0.78 | Upgrade
|
| Preferred Dividends Paid | - | - | - | - | - | -0.24 | Upgrade
|
| Dividends Paid | - | - | - | - | - | -0.24 | Upgrade
|
| Other Financing Activities | - | 10.38 | - | 2.81 | 5.39 | 17.05 | Upgrade
|
| Financing Cash Flow | 1.07 | 10.85 | 11.75 | 29.93 | 48.01 | 137.35 | Upgrade
|
| Net Cash Flow | -15.59 | 2.09 | 0.77 | 4.82 | -29.71 | 19.65 | Upgrade
|
| Free Cash Flow | -16.66 | -8.77 | -10.98 | -25.11 | -77.72 | -117.7 | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -29219.17% | - | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.03 | -0.12 | -0.20 | Upgrade
|
| Cash Interest Paid | - | 0.03 | 0.05 | 0.02 | 0.06 | 0.15 | Upgrade
|
| Levered Free Cash Flow | 4.27 | -4.3 | -43.19 | -31.93 | -102.87 | 15.22 | Upgrade
|
| Unlevered Free Cash Flow | 6.64 | -1.67 | -39.28 | -24.44 | -90.8 | 25.38 | Upgrade
|
| Change in Working Capital | 2.82 | -16.17 | 11.66 | -1.2 | -4.78 | -25.12 | Upgrade
|
Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.